Who owns NURIX THERAPEUTICS INC?
- Ticker: NRIX
- CUSIP Number: 67080m103
Tip: Access positions for across all investors
Analyze quarterly positions in Nurix Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nurix Therapeutics stock
Who bought or sold NURIX THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BlackRock | 4.6M | $67M | 1% | Mar 2024 |
|
| Redmile Group | 4.5M | $66M | 38% | Mar 2024 |
|
| Baker Bros. Advisors | 3.9M | $57M | 0% | Mar 2024 |
|
| ARK Investment Management | 2.6M | $39M | -18% | Mar 2024 |
|
| Vanguard Group | 2.6M | $38M | -1% | Mar 2024 |
|
| Morgan Stanley | 2.5M | $37M | 899% | Mar 2024 |
|
| T. Rowe Price Associates | 2.2M | $32M | -8% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 1.5M | $22M | 197% | Mar 2024 |
|
| Daniel D. Thurber | 1.2M | $18M | -55% | Mar 2024 |
|
| Bain Capital Life Sciences Investors | 1.1M | $17M | -38% | Mar 2024 |
|
| Soleus Capital Management | 1.1M | $16M | 680% | Mar 2024 |
|
| Geode Capital Management | 1.1M | $16M | 5% | Mar 2024 |
|
| Dimensional Fund Advisors | 967k | $14M | -3% | Mar 2024 |
|
| Candriam Luxembourg S.C.A. | 892k | $13M | -3% | Mar 2024 |
|
| Pictet Asset Management Holding SA | 727k | $11M | 100% | Mar 2024 |
|
| Charles Schwab Investment Management | 642k | $9.4M | 3% | Mar 2024 |
|
| Goldman Sachs Group | 493k | $7.2M | 75% | Mar 2024 |
|
| Jacobs Levy Equity Management | 434k | $6.4M | 74% | Mar 2024 |
|
| Nuveen Asset Management | 419k | $6.2M | -37% | Mar 2024 |
|
| Northern Trust | 404k | $5.9M | -8% | Mar 2024 |
|
| Millennium Management | 374k | $5.5M | -1% | Mar 2024 |
|
| Bessemer | 357k | $3.7M | 0% | Dec 2023 |
|
| Arrowpoint Asset Management | 315k | $4.6M | 0% | Mar 2024 |
|
| Ikarian Capital | 300k | $4.4M | 100% | Mar 2024 |
|
| Taddei, Ludwig & Associates | 283k | $4.2M | 0% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 262k | $3.9M | 100% | Mar 2024 |
|
| Parkman Healthcare Partners | 250k | $3.7M | 100% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 237k | $3.5M | 28% | Mar 2024 |
|
| Citadel Advisors | 220k | $3.2M | 342% | Mar 2024 |
|
| Rafferty Asset Management | 211k | $3.1M | 114% | Mar 2024 |
|
| Two Sigma Investments | 211k | $3.1M | 123% | Mar 2024 |
|
| Wellington Management Company | 205k | $2.1M | 42% | Dec 2023 |
|
| Arrowstreet Capital, Limited Partnership | 188k | $2.8M | -4% | Mar 2024 |
|
| Citigroup | 185k | $2.7M | 1120% | Mar 2024 |
|
| Two Sigma Advisers | 178k | $2.6M | 511% | Mar 2024 |
|
| UBS Group | 169k | $2.5M | 121% | Mar 2024 |
|
| ExodusPoint Capital Management | 166k | $2.4M | 230% | Mar 2024 |
|
| Acadian Asset Management | 160k | $2.4M | 100% | Mar 2024 |
|
| Trexquant Investment | 159k | $1.6M | 81% | Dec 2023 |
|
| Bank of New York Mellon | 159k | $2.3M | -8% | Mar 2024 |
|
| Susquehanna Portfolio Strategies | 158k | $2.3M | 100% | Mar 2024 |
|
| Massachusetts Financial Services | 113k | $1.7M | -21% | Mar 2024 |
|
| Ameriprise Financial | 106k | $1.6M | 76% | Mar 2024 |
|
| Thomas Stevens, CFA" | 102k | $1.5M | -19% | Mar 2024 |
|
| Susquehanna International | 98k | $1.4M | 70% | Mar 2024 |
|
| Bank of America Corporation | 97k | $1.4M | 413% | Mar 2024 |
|
| Jasper Ridge Partners | 96k | $1.4M | 0% | Mar 2024 |
|
| Kennedy Capital Management | 88k | $1.3M | -45% | Mar 2024 |
|
| Ensign Peak Advisors | 80k | $1.2M | 0% | Mar 2024 |
|
| Boothbay Fund Management | 80k | $1.2M | 100% | Mar 2024 |
|
| Rhumbline Advisers | 78k | $1.1M | 4% | Mar 2024 |
|
| FMR | 71k | $1.0M | -78% | Mar 2024 |
|
| Hsbc Holdings | 67k | $700k | 40% | Dec 2023 |
|
| PDT Partners | 67k | $989k | 100% | Mar 2024 |
|
| Franklin Resources | 65k | $948k | 185% | Mar 2024 |
|
| ClariVest Asset Management | 61k | $902k | 3% | Mar 2024 |
|
| American Century Companies | 60k | $883k | 95% | Mar 2024 |
|
| Pennant Investors | 57k | $835k | 100% | Mar 2024 |
|
| Jane Street | 57k | $834k | -24% | Mar 2024 |
|
| Russell Investments | 54k | $787k | 76% | Mar 2024 |
|
| Campbell & Co. Investment Adviser | 52k | $762k | 100% | Mar 2024 |
|
| Ohio Pers | 51k | $747k | 4% | Mar 2024 |
|
| Barclays | 48k | $698k | -31% | Mar 2024 |
|
| Alliancebernstein | 47k | $480k | 0% | Dec 2023 |
|
| Duquesne Family Office | 44k | $650k | 100% | Mar 2024 |
|
| Amundi | 44k | $632k | 0% | Mar 2024 |
|
| Cubist Systematic Strategies | 36k | $533k | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 36k | $523k | 100% | Mar 2024 |
|
| Jpmorgan Chase & Co | 34k | $515k | -28% | Mar 2024 |
|
| ProFund Advisors | 33k | $486k | 92% | Mar 2024 |
|
| Mariner Wealth Advisors | 32k | $464k | 0% | Mar 2024 |
|
| Mirae Asset Global Investments | 31k | $454k | 27% | Mar 2024 |
|
| Corton Capital | 27k | $402k | -31% | Mar 2024 |
|
| Blackstone Group | 27k | $399k | 0% | Mar 2024 |
|
| XTX Topco | 26k | $387k | 20% | Mar 2024 |
|
| American International | 24k | $244k | 0% | Dec 2023 |
|
| MetLife Investment Advisors | 23k | $240k | 0% | Dec 2023 |
|
| SG Americas Securities | 22k | $326k | -17% | Mar 2024 |
|
| Wells Fargo & Company | 21k | $311k | 10% | Mar 2024 |
|
| AtonRa Partners | 21k | $218k | -13% | Dec 2023 |
|
| BBR Partners | 21k | $309k | 0% | Mar 2024 |
|
| Exchange Traded Concepts | 20k | $298k | 28% | Mar 2024 |
|
| CornerCap Investment Counsel | 19k | $272k | 0% | Mar 2024 |
|
| J.w. Cole Advisors | 18k | $265k | 100% | Mar 2024 |
|
| Florida State Board of Administration | 18k | $155k | -1% | Mar 2024 |
|
| Deerfield Management Company | 17k | $243k | 5% | Mar 2024 |
|
| New York State Common Retirement Fund | 16k | $240k | 1% | Mar 2024 |
|
| Ing Investment Management | 16k | $235k | -52% | Mar 2024 |
|
| Jump Financial | 15k | $158k | 100% | Dec 2023 |
|
| Caxton Associates | 15k | $225k | 100% | Mar 2024 |
|
| Fiduciary Trust Company | 14k | $145k | 0% | Dec 2023 |
|
| Verition Fund Management | 13k | $194k | 100% | Mar 2024 |
|
| Principal Financial Group | 13k | $190k | -8% | Mar 2024 |
|
| 49 Wealth Management | 13k | $182k | -9% | Mar 2024 |
|
| AQR Capital Management | 12k | $177k | -56% | Mar 2024 |
|
| ProShare Advisors | 12k | $176k | 100% | Mar 2024 |
|
| Oracle Alpha | 12k | $170k | -34% | Mar 2024 |
|
| HPM Partners | 11k | $158k | 100% | Mar 2024 |
|
| Virtus ETF Advisers | 9.7k | $143k | -6% | Mar 2024 |
|
| Fernwood Investment Management | 9.7k | $142k | 100% | Mar 2024 |
|
| Point72 Asset Management | 9.5k | $140k | 100% | Mar 2024 |
|
| China Universal Asset Management | 9.4k | $138k | 68% | Mar 2024 |
|
| Quest Partners | 9.2k | $135k | 60% | Mar 2024 |
|
| Avalon Trust | 7.1k | $104k | 0% | Mar 2024 |
|
| Legal & General Group | 6.7k | $99k | -2% | Mar 2024 |
|
| nVerses Capital | 5.2k | $76k | 100% | Mar 2024 |
|
| California State Teachers Retirement System | 4.8k | $70k | -89% | Mar 2024 |
|
| Natixis | 4.8k | $70k | -17% | Mar 2024 |
|
| Simplex Trading | 4.6k | $67k | 6803% | Mar 2024 |
|
| Summit Investment Advisors | 4.6k | $68k | 0% | Mar 2024 |
|
| Metropolitan Life Insurance Company | 2.7k | $28k | 0% | Dec 2023 |
|
| Zurcher Kantonalbank | 1.8k | $26k | 100% | Mar 2024 |
|
| Amalgamated Bank | 1.5k | $23k | -62% | Mar 2024 |
|
| Tower Research Capital | 1.3k | $19k | 46% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 1.2k | $18k | 100% | Mar 2024 |
|
| Royal Bank of Canada | 1.2k | $12k | -92% | Mar 2024 |
|
| GAMMA Investing | 1.1k | $17k | 160% | Mar 2024 |
|
| Pacer Advisors | 985.00 | $15k | 100% | Mar 2024 |
|
| Signature | 483.00 | $7.1k | -29% | Mar 2024 |
|
| Us Bancorp | 304.00 | $4.5k | 311% | Mar 2024 |
|
| Daiwa Securities Group | 152.00 | $2.0k | 0% | Mar 2024 |
|
| NISA Investment Advisors | 99.00 | $1.5k | 296% | Mar 2024 |
|
| Brian McDonald | 96.00 | $1.4k | -63% | Mar 2024 |
|
| Quadrant Capital | 66.00 | $970.998600 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 9.00 | $132.000300 | 100% | Mar 2024 |
|
| Farther Finance Advisors | 9.00 | $131.000400 | 0% | Mar 2024 |
|
| Pnc Financial Services | 4.00 | $59.000000 | 100% | Mar 2024 |
|
Who sold out of Nurix Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Suvretta Capital Management | Sep 2023 | 281k | $2.2M |
| Norges Bank Investment Management | Dec 2023 | 258k | $2.7M |
| Raymond James & Associates | Dec 2023 | 101k | $1.0M |
| Hrt Financial | Dec 2023 | 86k | $890k |
| Denali Advisors | Dec 2023 | 58k | $593k |
| Algert Coldiron Investors | Sep 2023 | 42k | $333k |
| Bank Of Montreal | Dec 2023 | 27k | $294k |
| B. Metzler seel. Sohn & Co | Sep 2023 | 27k | $213k |
| GSA Capital Partners | Dec 2023 | 24k | $249k |
| State of Wisconsin Investment Board | Dec 2023 | 24k | $247k |
| Balyasny Asset Management | Dec 2023 | 23k | $233k |
| Tudor Investment Corporation | Dec 2023 | 22k | $228k |
| Man Group | Dec 2023 | 19k | $199k |
| Brevan Howard Capital Management | Dec 2023 | 11k | $114k |
| Lazard Asset Management | Sep 2023 | 5.7k | $44k |
| Allspring Global Investments Holdings | Dec 2023 | 1.0k | $11k |